Beijing Idmo Co.,ltd

Scientists and doctors have limited knowledge of how different people respond to different treatments. Today, personalized medicine is moving us closer to more precise, predictable and powerful medicine. Founded in 2014, IDMO, the genome engineering specialist, is devoted to developing the highly physiologically relevant animal models, whose value in drug development is becoming realized as individualized therapy approaches. Our growing understanding of genetics allows us to establish the very animal “patients”, in order to boost the ability of predicting drug effects in the individual patient.